US medtech will weather this storm: battered but not tattered
This article was originally published in Clinica
Executive Summary
The US medtech industry has fared better than most other industries in the storm that is the global economic recession. But it was not entirely immune, Ernst & Young analysts point out in a report released at the AdvaMed 2009 conference today.